Pemivibart has been available in the US since March 2024 under an emergency use authorisation for adults and adolescents aged ...

The FDA issued an emergency use authorization (EUA) for pemivibart (Pemgarda) as COVID-19 pre-exposure prophylaxis in immunocompromised individuals who are unlikely to mount a sufficient immune ...

A recent study co-authored by a Warren Alpert Medical School professor showed the effectiveness of convalescent plasma therapies for treating COVID-19 early in its disease course and preventing ...

Takeda (TSE:4502/NYSE:TAK) today announced that the recently FDA-approved HyHub and HyHub Duo devices are now available in the U.S. for patients 17 years of age and older, as prescribed, who are ...

This study showed CP therapy was well tolerated and could potentially improve the clinical outcomes through neutralizing viremia in severe COVID-19 cases. The optimal dose and time point, as well as ...

The shelf-life of Gohibic has been extended from 24 to 30 months, when stored at 2 to 8°C (36°F to 46°F) for certain lots. The Food and Drug Administration (FDA) has authorized an extension to the ...